The DSM, the ICD, and the Cost of a Label

A diagnosis is a judgment call turned into a shared language. The DSM (Diagnostic and Statistical Manual, used mainly in the United States) and the ICD (International Classification of Diseases, used worldwide) list specific criteria for each disorder: how many symptoms, how severe, how long they must last, and what else they rule out. A clinician checks a person's experience against that checklist. If enough boxes are checked, the person receives a named category instead of just a description of scattered symptoms. That name lets insurance pay for treatment, lets researchers study people with the same condition across different hospitals, and lets a patient finally have words for what is happening to them.

That same name has a shelf life problem. On the benefit side, a label can open doors immediately: medication, therapy covered by insurance, school accommodations, a support group of people who understand. On the cost side, the label does not expire when symptoms do. Someone diagnosed with a disorder in their twenties may still be seen through that lens at fifty, even fully recovered, facing assumptions about reliability, parenting, or employability. The timeline matters: benefits often arrive fast and cluster around treatment, while costs like stigma can linger indefinitely and attach to the person rather than the illness.

Manuals themselves change. When a new edition is published, criteria get rewritten as research shifts, so some people who qualified for a diagnosis under the old rules no longer qualify under the new ones, and others newly qualify. This connects classification directly to the next idea in the unit: treatment approaches are chosen based on whatever diagnostic category currently applies, so a shifting manual can shift who gets which treatment.